|
|
|
|
|
|
|
|
|
|
Reuters
".....French drugmaker Sanofi acquired global rights to the Merrimack drug MM-121, being tested in lung, breast and ovarian cancer."
Thursday, May 23, 2013
Thrifty Merrimack developing new cancer drugs at lower cost | Reuters
Reuters
".....French drugmaker Sanofi acquired global rights to the Merrimack drug MM-121, being tested in lung, breast and ovarian cancer."
Subscribe to:
Post Comments
(
Atom
)
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.